C-Peptide thanks for the clarification of the press release. I was a bit confused myself. Was the MKC-1 trial a dose escalating trial? If so, could it be that the earlier patients had doses too low and as the trial continued the dose levels were raised and hopefully the patients lived longer. I guess we will have to wait for the data.